View up-to-date information on Axsome Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US20220280524A1 | Application | REBOXETINE TO TREAT NARCOLEPSY | A61K31/5375; A61P25/02; A61P25/20 | September 08, 2022 |
US11433035B2 | Grant | Dosage forms and methods for enantiomerically enriched or pure bupropion | A61K31/137; A61K9/0053; A61K9/0095; A61K9/20; A61K9/48 | September 06, 2022 |
US11433078B2 | Grant | Pharmaceutical compositions comprising meloxicam | A61K31/4196; A61K31/5415; A61K33/00; A61K47/02; A61K47/40; A61K47/6951; A61P25/06 | September 06, 2022 |
US11433079B2 | Grant | Pharmaceutical compositions comprising meloxicam | A61K31/4196; A61K31/5415; A61K47/02; A61K47/61; A61P1/08; A61P25/06; A61P29/00 | September 06, 2022 |
US11426414B2 | Grant | Pharmaceutical compositions comprising meloxicam | A61K31/4196; A61K31/5415; A61K47/02; A61K47/40; A61K47/6951; A61K9/0053; A61K9/2009; A61K9/205; A61K9/2086; A61K9/209; A61P29/00 | August 30, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer